|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 115.05 USD | -0.04% |
|
+0.19% | +76.46% |
| Apr. 17 | Gilead Sciences Says All Required Regulatory Approvals Received for Arcellx Acquisition | MT |
| Apr. 08 | Gilead Sciences' Tubulis Buy Underscores Shift Beyond HIV, Oppenheimer Says | MT |
| Capitalization | 6.75B 5.75B 5.29B 5.01B 9.25B 625B 9.46B 62.01B 24.29B 303B 25.32B 24.79B 1,074B | P/E ratio 2026 * |
-30.4x | P/E ratio 2027 * | -74.4x |
|---|---|---|---|---|---|
| Enterprise value | 6.24B 5.32B 4.89B 4.63B 8.56B 578B 8.75B 57.34B 22.46B 280B 23.42B 22.93B 993B | EV / Sales 2026 * |
81.5x | EV / Sales 2027 * | 23.5x |
| Free-Float |
80.19% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Arcellx, Inc.
| 1 day | -0.04% | ||
| 1 week | +0.19% | ||
| Current month | +0.20% | ||
| 1 month | +0.63% | ||
| 3 months | +66.88% | ||
| 6 months | +32.26% | ||
| Current year | +76.46% |
| 1 week | 114.86 |  | 115.13 |
| 1 month | 114.39 | | 115.13 |
| Current year | 60.36 | | 115.13 |
| 1 year | 47.86 | | 115.13 |
| 3 years | 30.74 | | 115.13 |
| 5 years | 6.04 | | 115.13 |
| 10 years | 6.04 | | 115.13 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rami Elghandour
CEO | Chief Executive Officer | 47 | 2021-01-21 |
Michelle Gilson
DFI | Director of Finance/CFO | 34 | 2022-05-22 |
Aileen Fernandes
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jill Carroll
BRD | Director/Board Member | 50 | 2017-08-31 |
Ali Behbahani
BRD | Director/Board Member | 49 | 2015-01-31 |
Rami Elghandour
CHM | Chairman | 47 | 2021-01-21 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.04% | +0.19% | +85.50% | +226.29% | 6.75B | |
| +2.22% | +5.51% | +0.78% | -6.34% | 48.69B | |
| +0.99% | +4.59% | +40.22% | +25.29% | 35.92B | |
| -0.43% | +54.13% | +304.33% | +490.27% | 31.26B | |
| -0.72% | +3.91% | +37.10% | +32.51% | 29.77B | |
| +2.62% | +5.45% | +22.62% | -12.58% | 29.62B | |
| +0.63% | +2.17% | +48.12% | +194.45% | 15.1B | |
| +0.96% | +5.48% | +75.71% | +169.35% | 14.87B | |
| +0.87% | +8.85% | +40.89% | +14.87% | 14.5B | |
| -6.22% | -0.52% | +3,641.35% | +3,861.59% | 14.18B | |
| Average | +0.09% | +8.85% | +429.66% | +499.57% | 24.07B | |
| Weighted average by Cap. | +0.56% | +10.81% | +280.12% | +326.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 76.57M 65.21M 59.98M 56.78M 105M 7.09B 107M 703M 275M 3.43B 287M 281M 12.18B | 274M 233M 214M 203M 375M 25.34B 384M 2.51B 985M 12.27B 1.03B 1.01B 43.56B |
| Net income | -207M -176M -162M -153M -283M -19.13B -289M -1.9B -743M -9.26B -775M -759M -32.88B | -85.32M -72.66M -66.84M -63.27M -117M -7.9B -120M -784M -307M -3.82B -320M -313M -13.58B |
| Net Debt | -508M -433M -398M -377M -696M -47.03B -712M -4.67B -1.83B -22.77B -1.91B -1.87B -80.84B | -327M -278M -256M -242M -448M -30.26B -458M -3B -1.18B -14.65B -1.23B -1.2B -52.01B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-04-17 | 115.05 $ | -0.04% | 479,538 |
| 26-04-16 | 115.10 $ | +0.09% | 434,554 |
| 26-04-15 | 115.00 $ | +0.10% | 588,997 |
| 26-04-14 | 114.89 $ | +0.02% | 543,081 |
| 26-04-13 | 114.87 $ | +0.03% | 486,092 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ACLX Stock
Select your edition
All financial news and data tailored to specific country editions
